ZA894280B - Treatment of arthritis - Google Patents

Treatment of arthritis

Info

Publication number
ZA894280B
ZA894280B ZA894280A ZA894280A ZA894280B ZA 894280 B ZA894280 B ZA 894280B ZA 894280 A ZA894280 A ZA 894280A ZA 894280 A ZA894280 A ZA 894280A ZA 894280 B ZA894280 B ZA 894280B
Authority
ZA
South Africa
Prior art keywords
arthritis
treatment
Prior art date
Application number
ZA894280A
Other languages
English (en)
Inventor
Jean Honore M Feyen
Honore M Feyen Jean
Janos Pless
Pless Janos
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA894280B publication Critical patent/ZA894280B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/31Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA894280A 1988-06-06 1989-06-06 Treatment of arthritis ZA894280B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813339A GB8813339D0 (en) 1988-06-06 1988-06-06 Improvements in/relating to organic compounds

Publications (1)

Publication Number Publication Date
ZA894280B true ZA894280B (en) 1991-02-27

Family

ID=10638146

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894280A ZA894280B (en) 1988-06-06 1989-06-06 Treatment of arthritis

Country Status (18)

Country Link
US (1) US5145837A (de)
EP (1) EP0351354A3 (de)
JP (1) JP2809707B2 (de)
KR (1) KR910000178A (de)
AU (1) AU631547B2 (de)
BE (1) BE1004038A4 (de)
CH (1) CH680924A5 (de)
DE (1) DE3918320A1 (de)
DK (1) DK273089A (de)
FR (1) FR2632188B1 (de)
GB (2) GB8813339D0 (de)
HU (1) HU206633B (de)
IT (1) IT1231521B (de)
MY (1) MY104129A (de)
NL (1) NL8901435A (de)
PT (1) PT90753A (de)
SE (1) SE8902042L (de)
ZA (1) ZA894280B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001960A (en) * 1992-09-01 1999-12-14 The Trustees Of The University Of Pennsylvania Synthetic somatostatin mimics
US5700905A (en) * 1992-09-01 1997-12-23 The Trustees Of The University Of Pennsylvania Synthetic somatostatin mimics
US5965694A (en) * 1992-09-01 1999-10-12 The Trustees Of The University Of Pennsylvania Somatostatin mimics and synthetic methods therefor
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
US5686418A (en) * 1996-04-08 1997-11-11 Biomeasure Incorporated Prolonging survival of transplanted pancreatic cells
UA66401C2 (en) * 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
US6146639A (en) * 1999-07-26 2000-11-14 Merich Nick Arthritis, muscle pain, and dry skin remedy
US20020115695A1 (en) * 2000-11-07 2002-08-22 Paralkar Vishwas M. Combination therapies for the stimulation of bone growth
CA2449634C (en) * 2001-06-08 2011-08-02 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R Somatostatin-dopamine chimeric analogs
ES2327913T3 (es) * 2002-03-04 2009-11-05 Ipsen Pharma Formulaciones de medicamentos de liberacion sostenida que contienen un peptido portador.
US7521427B2 (en) * 2004-11-09 2009-04-21 Georgia Tech Research Corporation Peptidyl allyl sulfones
JP2016503402A (ja) 2012-11-01 2016-02-04 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエIpsen Pharma S.A.S. ソマトスタチン類似体及びそのダイマー
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素-多巴胺嵌合體類似物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970571A (en) * 1974-12-20 1976-07-20 Eastman Kodak Company Method for producing improved electrographic developer
DE3114824A1 (de) * 1980-05-07 1982-04-08 Gerhard Prof.Dr.med. 8500 Nürnberg Weber "verwendung eines mittels zur behandlung der psoriasis (schuppenflechte)"
JPS5978364A (ja) * 1982-10-28 1984-05-07 Ricoh Co Ltd 電気的潜像現像用トナ−
US4474766A (en) * 1983-06-27 1984-10-02 Merck & Co., Inc. Anti-inflammatory/analgesic combination of cyclo-(N-methyl-Ala-Tyr-D-Trp-Lys-Val-Phe) and a selected non-steroidal anti-inflammatory drug (NSAID)
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
JPS61258268A (ja) * 1985-05-13 1986-11-15 Canon Inc 静電荷像現像用電荷付与材
JPS638652A (ja) * 1986-06-27 1988-01-14 Ricoh Co Ltd 静電荷像現像用トナ−
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
IT1208760B (it) * 1986-11-04 1989-07-10 Ind Farmaceutica Serono S P A Trattamento delle malattie infiammatorie articolari
CH679045A5 (de) * 1987-06-29 1991-12-13 Sandoz Ag
DE3845000C2 (de) * 1987-07-10 1998-11-19 Novartis Ag Anwendung von Octreotid zur Behandlung von Brustkrebs

Also Published As

Publication number Publication date
DK273089D0 (da) 1989-06-02
JP2809707B2 (ja) 1998-10-15
DE3918320A1 (de) 1989-12-14
IT1231521B (it) 1991-12-07
KR910000178A (ko) 1991-01-29
MY104129A (en) 1994-02-28
GB8813339D0 (en) 1988-07-13
AU631547B2 (en) 1992-12-03
HUT53291A (en) 1990-10-28
FR2632188B1 (fr) 1994-10-07
JPH0242026A (ja) 1990-02-13
GB2219503A (en) 1989-12-13
BE1004038A4 (fr) 1992-09-15
FR2632188A1 (fr) 1989-12-08
NL8901435A (nl) 1990-01-02
GB8912724D0 (en) 1989-07-19
US5145837A (en) 1992-09-08
AU3604289A (en) 1989-12-07
GB2219503B (en) 1992-04-29
DK273089A (da) 1989-12-07
SE8902042D0 (sv) 1989-06-05
CH680924A5 (de) 1992-12-15
EP0351354A2 (de) 1990-01-17
IT8948041A0 (it) 1989-06-05
HU206633B (en) 1992-12-28
EP0351354A3 (de) 1991-11-06
PT90753A (pt) 1989-12-29
SE8902042L (sv) 1990-03-28

Similar Documents

Publication Publication Date Title
GB8716133D0 (en) Treatment of materials
ZA899058B (en) Treatment of obesity
GB2219503B (en) Treatment of arthritis
AR243138A1 (es) Procedimiento para el tratamiento de un efluente acuoso.
GB8809205D0 (en) Treatment of oedema
GB8810748D0 (en) Novel treatment
GB8828679D0 (en) Novel treatment
IE891751L (en) Treatment of arthritis
GB8816505D0 (en) Novel treatment
GB8827043D0 (en) Treatment of materials
GB8826819D0 (en) Treatment of sewage
ZA902990B (en) Treatment of minerals
GB8903284D0 (en) Treatment of materials
GB8610698D0 (en) Treatment of rheumatoid arthritis
GB8618921D0 (en) Treatment for arthritis
IE883123L (en) Treatment of immunodeficiency
GB8818271D0 (en) Treatment of immunodeficiency
GB8813641D0 (en) Treatment of immunodeficiency
GB8808033D0 (en) Novel treatment
GB8820102D0 (en) Novel treatment
GB8802254D0 (en) Novel treatment
GB8814811D0 (en) Novel treatment
GB8816506D0 (en) Novel treatment
GB8819577D0 (en) Novel treatment
GB8826569D0 (en) Novel treatment